Andra AP fonden Lowers Position in GE HealthCare Technologies Inc. $GEHC

Andra AP fonden trimmed its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 93.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,800 shares of the company’s stock after selling 55,200 shares during the quarter. Andra AP fonden’s holdings in GE HealthCare Technologies were worth $285,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in GEHC. Dodge & Cox raised its stake in shares of GE HealthCare Technologies by 42.1% during the 2nd quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock worth $1,745,678,000 after buying an additional 6,982,441 shares in the last quarter. Norges Bank acquired a new position in GE HealthCare Technologies during the second quarter worth $468,120,000. Holocene Advisors LP raised its position in GE HealthCare Technologies by 178.5% in the second quarter. Holocene Advisors LP now owns 4,027,352 shares of the company’s stock worth $298,306,000 after acquiring an additional 2,581,522 shares in the last quarter. Menora Mivtachim Holdings LTD. acquired a new stake in GE HealthCare Technologies in the second quarter valued at $80,755,000. Finally, Balyasny Asset Management L.P. purchased a new stake in shares of GE HealthCare Technologies during the 2nd quarter worth $58,388,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

Wall Street Analyst Weigh In

GEHC has been the subject of several recent analyst reports. Citigroup raised their price objective on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the company a “neutral” rating in a research note on Thursday, December 11th. BTIG Research lifted their price target on shares of GE HealthCare Technologies from $87.00 to $91.00 and gave the company a “buy” rating in a research report on Wednesday, February 4th. Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Monday, December 29th. Stifel Nicolaus raised their price objective on GE HealthCare Technologies from $95.00 to $98.00 and gave the company a “buy” rating in a research note on Wednesday, February 4th. Finally, Bank of America boosted their target price on GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a research report on Monday, January 5th. Seven equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $92.50.

GE HealthCare Technologies Stock Up 0.4%

Shares of NASDAQ:GEHC opened at $84.27 on Monday. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $90.26. The stock’s 50-day moving average price is $82.38 and its two-hundred day moving average price is $78.46. The company has a current ratio of 1.37, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91. The firm has a market cap of $38.41 billion, a price-to-earnings ratio of 18.48, a PEG ratio of 1.85 and a beta of 1.03.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, topping the consensus estimate of $1.40 by $0.04. The firm had revenue of $5.70 billion during the quarter, compared to analyst estimates of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. GE HealthCare Technologies’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be paid a dividend of $0.035 per share. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is currently 3.07%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.